{"ticker": {"uuid": "206701f8-b422-4363-a08c-1721c5d472cc", "symbol": "IPN", "name": "Ipsen S.A.", "exchange": "VIE", "country": "AT", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Ipsen (ENXTPA:IPN) Stock Looks Like A Bargain On Cash Flow But Full On Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQZGpVVjRLQldGSWRfaS10eWx4UUVwaktlbXg1Y0piUHc1OTdoRHdkU29VdXlRZXNIcF9XX3RDOWtPQi1LbWpIcW9ObXhMUGRJbm5ISkd4a3VsajVRQXMwWWMzNVR2cGZjOFNLd0xpd0ZaSUxDT1JOZXA3ZGVDeDFXX3hic0dpdkpvYkxJcmRSQ2xoS1dwM1FKeA?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Adds A Buy Back, Is The Stock Fully Priced?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOemR1NWlRNFh3SmI0MnEyY3ozaGJNNXBrMm4zbnBTWXBLYkxsWlNfd1FnMzFGVEtIY3FHTGdFLVBHaldrbTliN25PSVZKYk1LMkh2dHNOZXBobUJDWWJaM0x4Wm9kc19qNFJ5dndMaEtYQmVPZ2pscnZHZDhBc25vVHYxR1BZaWFEMUJIOW9oajNvUzNUeE1KcHd5NUV0cEtLTjNlRkR6NVhHc3BCc0ZsWFdtNHd3WWlOb0VfLUJnUnJuQkVIUEdEX2tRTHd1ZXZIbmZzcEpB0gHbAUFVX3lxTFBkSVA2YjdvT2RMSExqdENocGtLVHpUMlB0UDRBSUhzVGJGakkwZ0syaUVPNFJKVXhobUE0Y01UbjdQVmRCcjc1Y1BVOWtzbVFXeTlaNDVDeXRHbGE0UjE1ZU83YV9CYTBndmxhZVpkLWM0UmRCdTJqa0MxaC1rSktvNnVpSk4xazNRdnN1OFdwQnh6dHhJZUZlZWRXNVJyT25QU3hsNHBSd0VsQmFrVkZVUnhLRjhxa3Y0REdpcG5iLWFiUzdiQ29iZWMzaGRlVmt2VEJSdUJkTGs5OA?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-06T14:01:49+00:00", "published_display": "06 Jul 2026 14:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen SA Actuals & Estimates (EURONEXT:IPN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNTTFZNUZ6SzlIZ2RYRGN6RlpuOFZHUkZMLUV3dFMtQk1xekl1bU9QVk5SU2x4dnlGNUpMa1ROMVZKMS1qZjFHV3JTaVhLaVJpSDFneVlqeUJLemRYckwwRi1MLTNKRGhXcmZaR1BUN3BTVnVXSU9XUGUxMEJyWjVQWDZxNTdaR2s?oc=5", "source_name": "TradingView", "published_at": "2026-06-25T16:32:33+00:00", "published_display": "25 Jun 2026 16:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Valuation Check After A Strong Year-To-Date Rise And Recent Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNMFFiajVtUHNKcFBBZVFUSlQtalEzOEc2a2k2MVVjZ3RubWJicEhVTGlkeUIwMkZpR1RVbHVYZy10dG54MF9KcTY5LWxFSWRoeGZEOHlTS1FmQkZwVXM2TmpabW9VMjJZSFBYbjVvYVp1b0ItMGxlU01UVHp5ai1hWTFIS2UxTGxtMHB1ZEFuVkItellNUllWY01nYlBDZw?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen announces the launch of an Employee Shareholding Plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZEc0QmVCdlBpNVJSeUE0S1J2ZkFSR1J2b0hpTm43N2FNbGdjQ1JyM0dQckRfMTc5M21Hb0gwSlZSUFlyRUJHNGdrWnJCbTVTVGlFYmJEa0w1dGxRVlk4YVQ1SWk5b0RTTU04Q2ZNa0ZDeVVmdURIRkNWUkJ2a1NyeTR2M1BDaVdaVmZHZy1qSFNQWGpsUFozMDUtZkZ5b2Y0SklKTUc1S1JRdzRDVlE?oc=5", "source_name": "Market source", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen stock falls as Galderma feud clouds strong corabotase data", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQaFZaMlVfcU1TTW9VVnhfZnBKWlNfajNCaGpsTE02Q0hHeHp3aWRyZFFHRVVwdkx3LTE3MExCNU1iaFVkcE1IZGdrcnJ5V2ZzTDZ1X3I4R2VrR19CQzJkVGYwdFgzSE1yejVXWjJkOGtJMWJmVmRnY1Y3QzF5Z1J0ZGtIcTZ0UGlSakU5YTJxeHQybzJOS010dGZYYjZUYmIyenR4S1VBTG1jdW1rYldEalpkWWhnM1BFbmdCcUdB?oc=5", "source_name": "Investing.com", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Valuation Check After Strong Recent Share Price Performance", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOcjBlaktzS0dQX3Y4Z3lEdVpWRlJHV1RXb2VudDBRWHNmRm90NVBjMzdzUFQ3NVZ2TEZHVGxOV0ozak1va0IySS1BNFktTjBNQVZncnpZSUFJcGxGV29HX25OUDNhUzdZRk43U1FEUERVNUhzZGNCdW5uemRqRTF2ZHBFWDhpOHFUN1I5Q0JSNHQtSFZBY0l4djFGMTFxZw?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Ipsen (ENXTPA:IPN) After Its 65% One-Year Share Price Jump", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNREt1dlNJOGRxZEN2a0Z6UU16OWQwRmIycTJrSUZMakhSZTcxYjk5WHJrZEdmWk9yeFpSZ1J4cnZ4WUxyOWd5T3BBQ2F6SlBNR1Q4SHBqdjRXMG1JNWFxYzVFeWpWV2NBZ2c3NVJEQ1puUXFsdGhQVi0xNzJSTW8wVGpOTGhmMTNtZEMxNFAtTl9ucEtId3d1cGdHSQ?oc=5", "source_name": "Market source", "published_at": "2026-04-04T07:00:00+00:00", "published_display": "04 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen\u2019s IPN10200 Demonstrates Long-Lasting Efficacy in Phase II LANTIC Trial for Glabellar Lines", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNZTlzV2ZaYzRUYnBMMVpoY3NwNjFFMC1vQm8xSFlSUlh5YThqVUVSUmRMdWZuLXVyM05pWlJLR2JIYnZBeWVNdlg0dWVySDVKUkZaODFhQnkyR042QkxpZmc5WkxVUlJZRFFXSlcwVGl5OFcxZzhzOEo3LTN4a0psWWRnazJsWlVtWjZERDRRb3h2VWpLWmx2RDdQX1k1bE42cVVnZTYzN3RJdTBncmZzMWpwa2k?oc=5", "source_name": "Applied Clinical Trials Online", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen Earnings: Dysport & Cabometyx Drive Growth as Pipeline Develops; Shares Slightly Undervalued", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQTzZZN0hVNzRWOGpCWnB0bWd5V2FreFRzUU9nc1ZMZlU4amRBQngtLXdLaVdBclNoZnZxRGNpaFpWZl9neDZvUnNGYjY1VHdMX045R2lSMW5kNjlVS1ZWcTlQRWJmYkNOY01wSURfRU56aHFKTDVobjMtSllwLTNsRGwtM0JvSEVlMkowV2ZmYUVxZ1dTdFVIbWs1RDFyQUEzWGF6NUZzbXF5NjRfaFlpaG9TekZNNllXdVdYR0hZQ3cydGY5?oc=5", "source_name": "Morningstar", "published_at": "2023-10-30T07:00:00+00:00", "published_display": "30 Oct 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Ipsen (ENXTPA:IPN) Stock Looks Like A Bargain On Cash Flow But Full On Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQZGpVVjRLQldGSWRfaS10eWx4UUVwaktlbXg1Y0piUHc1OTdoRHdkU29VdXlRZXNIcF9XX3RDOWtPQi1LbWpIcW9ObXhMUGRJbm5ISkd4a3VsajVRQXMwWWMzNVR2cGZjOFNLd0xpd0ZaSUxDT1JOZXA3ZGVDeDFXX3hic0dpdkpvYkxJcmRSQ2xoS1dwM1FKeA?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Adds A Buy Back, Is The Stock Fully Priced?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-06T14:01:49+00:00", "published_display": "06 Jul 2026 14:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen SA Actuals & Estimates (EURONEXT:IPN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNTTFZNUZ6SzlIZ2RYRGN6RlpuOFZHUkZMLUV3dFMtQk1xekl1bU9QVk5SU2x4dnlGNUpMa1ROMVZKMS1qZjFHV3JTaVhLaVJpSDFneVlqeUJLemRYckwwRi1MLTNKRGhXcmZaR1BUN3BTVnVXSU9XUGUxMEJyWjVQWDZxNTdaR2s?oc=5", "source_name": "TradingView", "published_at": "2026-06-25T16:32:33+00:00", "published_display": "25 Jun 2026 16:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Valuation Check After A Strong Year-To-Date Rise And Recent Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNMFFiajVtUHNKcFBBZVFUSlQtalEzOEc2a2k2MVVjZ3RubWJicEhVTGlkeUIwMkZpR1RVbHVYZy10dG54MF9KcTY5LWxFSWRoeGZEOHlTS1FmQkZwVXM2TmpabW9VMjJZSFBYbjVvYVp1b0ItMGxlU01UVHp5ai1hWTFIS2UxTGxtMHB1ZEFuVkItellNUllWY01nYlBDZw?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen announces the launch of an Employee Shareholding Plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZEc0QmVCdlBpNVJSeUE0S1J2ZkFSR1J2b0hpTm43N2FNbGdjQ1JyM0dQckRfMTc5M21Hb0gwSlZSUFlyRUJHNGdrWnJCbTVTVGlFYmJEa0w1dGxRVlk4YVQ1SWk5b0RTTU04Q2ZNa0ZDeVVmdURIRkNWUkJ2a1NyeTR2M1BDaVdaVmZHZy1qSFNQWGpsUFozMDUtZkZ5b2Y0SklKTUc1S1JRdzRDVlE?oc=5", "source_name": "Market source", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen stock falls as Galderma feud clouds strong corabotase data", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQaFZaMlVfcU1TTW9VVnhfZnBKWlNfajNCaGpsTE02Q0hHeHp3aWRyZFFHRVVwdkx3LTE3MExCNU1iaFVkcE1IZGdrcnJ5V2ZzTDZ1X3I4R2VrR19CQzJkVGYwdFgzSE1yejVXWjJkOGtJMWJmVmRnY1Y3QzF5Z1J0ZGtIcTZ0UGlSakU5YTJxeHQybzJOS010dGZYYjZUYmIyenR4S1VBTG1jdW1rYldEalpkWWhnM1BFbmdCcUdB?oc=5", "source_name": "Investing.com", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen (ENXTPA:IPN) Valuation Check After Strong Recent Share Price Performance", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOcjBlaktzS0dQX3Y4Z3lEdVpWRlJHV1RXb2VudDBRWHNmRm90NVBjMzdzUFQ3NVZ2TEZHVGxOV0ozak1va0IySS1BNFktTjBNQVZncnpZSUFJcGxGV29HX25OUDNhUzdZRk43U1FEUERVNUhzZGNCdW5uemRqRTF2ZHBFWDhpOHFUN1I5Q0JSNHQtSFZBY0l4djFGMTFxZw?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Ipsen (ENXTPA:IPN) After Its 65% One-Year Share Price Jump", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNREt1dlNJOGRxZEN2a0Z6UU16OWQwRmIycTJrSUZMakhSZTcxYjk5WHJrZEdmWk9yeFpSZ1J4cnZ4WUxyOWd5T3BBQ2F6SlBNR1Q4SHBqdjRXMG1JNWFxYzVFeWpWV2NBZ2c3NVJEQ1puUXFsdGhQVi0xNzJSTW8wVGpOTGhmMTNtZEMxNFAtTl9ucEtId3d1cGdHSQ?oc=5", "source_name": "Market source", "published_at": "2026-04-04T07:00:00+00:00", "published_display": "04 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen\u2019s IPN10200 Demonstrates Long-Lasting Efficacy in Phase II LANTIC Trial for Glabellar Lines", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNZTlzV2ZaYzRUYnBMMVpoY3NwNjFFMC1vQm8xSFlSUlh5YThqVUVSUmRMdWZuLXVyM05pWlJLR2JIYnZBeWVNdlg0dWVySDVKUkZaODFhQnkyR042QkxpZmc5WkxVUlJZRFFXSlcwVGl5OFcxZzhzOEo3LTN4a0psWWRnazJsWlVtWjZERDRRb3h2VWpLWmx2RDdQX1k1bE42cVVnZTYzN3RJdTBncmZzMWpwa2k?oc=5", "source_name": "Applied Clinical Trials Online", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ipsen Earnings: Dysport & Cabometyx Drive Growth as Pipeline Develops; Shares Slightly Undervalued", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQTzZZN0hVNzRWOGpCWnB0bWd5V2FreFRzUU9nc1ZMZlU4amRBQngtLXdLaVdBclNoZnZxRGNpaFpWZl9neDZvUnNGYjY1VHdMX045R2lSMW5kNjlVS1ZWcTlQRWJmYkNOY01wSURfRU56aHFKTDVobjMtSllwLTNsRGwtM0JvSEVlMkowV2ZmYUVxZ1dTdFVIbWs1RDFyQUEzWGF6NUZzbXF5NjRfaFlpaG9TekZNNllXdVdYR0hZQ3cydGY5?oc=5", "source_name": "Morningstar", "published_at": "2023-10-30T07:00:00+00:00", "published_display": "30 Oct 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 55, "total_relevant": 10, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 5, "score": 56, "total": 10, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 86, "events": [{"event": "general", "label": "Market update", "weight": 4.4, "count": 8}, {"event": "earnings", "label": "Earnings", "weight": 1.45, "count": 2}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 162.0, "latest_week": "2026-07-10", "one_week_move": -4.8, "four_week_move": 2.9, "twelve_week_move": 1.3, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.374564, "market_dynamics_buy_signal": false, "relative_strength": -2.822868, "fair_value_gap": 37.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 47.9684, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.8% over one week, +2.9% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 67, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 5}, {"label": "simplywall.st", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "Investing.com", "count": 1}, {"label": "Applied Clinical Trials Online", "count": 1}, {"label": "Morningstar", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 10}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 8}, {"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "10", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-4.8% over one week, +2.9% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Ipsen (ENXTPA:IPN) Stock Looks Like A Bargain On Cash Flow But Full On Earnings"}], "updated_at": "2026-07-17T20:10:19.878273+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}